GlaxoSmithKline Pharmaceuticals reported a strong second quarter for FY27, with consolidated revenue rising to Rs 1,183.57 crore and net profit climbing to Rs 335.88 crore. The company also announced the appointment of Sandeep Seth as Head of Ethics & Compliance and proposed Walker Chandiok & Co LLP as its new statutory auditor effective from FY2027-28.
GlaxoSmithKline Pharma Reports Strong Q2 FY27 Performance
Consolidated Revenue: Rs 1,183.57 crore | Consolidated Net Profit: Rs 335.88 crore
Reader Takeaway: Robust top-line growth drives profitability, while new governance appointments signal long-term structural strengthening for the pharmaceutical major.
What just happened
GlaxoSmithKline Pharmaceuticals (GSK) announced its financial results for the quarter ending September 30, 2026. The company reported a significant increase in both revenue and profit compared to the same period last year. Consolidated revenue climbed to Rs 1,183.57 crore from Rs 979.94 crore in Q2 FY26. Consequently, net profit surged to Rs 335.88 crore, compared to Rs 257.49 crore reported in the year-ago quarter.
Why this matters
The financial results demonstrate sustained operational momentum for the company. Alongside the performance, the Board of Directors finalized critical governance updates. Mr. Sandeep Seth has been appointed as the Head of Ethics & Compliance, effective November 3, 2026, bringing over two decades of industry expertise to the role. Additionally, the company is transitioning its statutory audit responsibility, proposing M/s Walker Chandiok & Co LLP for a five-year term starting from FY 2027-28.
Governance and Management Update
The appointment of a dedicated Head of Ethics & Compliance aims to strengthen the company’s internal governance framework. The change in statutory auditor for the upcoming fiscal years follows standard corporate rotation practices and remains subject to approval by shareholders at the relevant Annual General Meeting.
Context Metrics
For the first half (H1) of FY27, the company recorded total revenue of Rs 2,122.01 crore, up from Rs 1,785.11 crore in H1 FY26. Net profit for the half-year period reached Rs 573.06 crore, compared to Rs 462.50 crore in the same period last year.
What to track next
Investors should monitor the integration of the new compliance leadership and look for official communication regarding the shareholder vote on the proposed auditor appointment. Continued revenue growth in coming quarters will be the key metric for sustaining current valuation trends.